Submission Details
| 510(k) Number | K192538 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 16, 2019 |
| Decision Date | September 04, 2020 |
| Days to Decision | 354 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K192538 is an FDA 510(k) clearance for the BD Syringe NRFit Lok and BD Syringe NRFit Slip, a Piston Syringe With Neuraxial Connector ? Epidural, Peripheral, And/or Indirect Cerebral Spinal Fluid Contact (Class II — Special Controls, product code QEH), submitted by Becton, Dickinson and Company (Franklin Lakes, US). The FDA issued a Cleared decision on September 4, 2020, 354 days after receiving the submission on September 16, 2019. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5860.
| 510(k) Number | K192538 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 16, 2019 |
| Decision Date | September 04, 2020 |
| Days to Decision | 354 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | QEH — Piston Syringe With Neuraxial Connector ? Epidural, Peripheral, And/or Indirect Cerebral Spinal Fluid Contact |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5860 |
| Definition | A Neuraxial Piston Syringe Is Intended To Inject Or Withdraw Fluid From The Neuraxial Space With Neuraxial Specific Connections. This Product Code May Include Epidural, Peripheral, Subarachnoid/spinal Block, Intrathecal And/or Intracerebroventricular Administration Routes. The Connector For Neuraxial Applications Is Intended To Facilitate Ansi/aami/iso 80369-6:2016 Compliant Neuraxial Specific Connections. |